BSECompany Update27 Aug 2026 · 27 Aug 2026, 06:28 pm

The Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting ("AGM") and the Annual Report of the Company for the Financial ....

Eiko Lifesciences Ltd · 540204

✦ AI Summarycompliance

Eiko Lifesciences Ltd has sent a letter to the BSE, informing them that the company has provided a weblink and QR code for accessing the Notice convening the 49th Annual General Meeting (AGM) and the Annual Report for the Financial Year 2025-26, to shareholders who have not registered their email addresses or hold physical shares.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Eiko Lifesciences Ltd - 540204 - Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('The Listing Regulations')

Attachments (1)

📄

f76a2088-1149-4582-a757-99a45614618c.pdf

pdf

Download →
View document text
Date: 27th August, 2026 Corporate Services Department, BSE Limited, Phiroze Jeejeebhoy Towers, 1st Floor, Dalal Street, Fort, Mumbai - 400001. Scrip Code: 540204 Sub: Compliance under Regulation 36 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir/ Madam, Pursuant to the requirements of Regulation 36(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform the Exchange that the Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting ("AGM") and the Annual Report of the Company for the Financial Year 2025-26, to the following categories of shareholders: i. Shareholders who have not registered their email addresses with the Company, its Registrar and Share Transfer Agent ("RTA"), or the Depository Participants ("DPs"); ii. Shareholders who have registered their email addresses with the Company, its RTA, or the DPs, but to whom the Notice could not be delivered on account of an invalid email address; iii. Shareholders who have registered their email addresses with the Company, its RTA, or the DPs, but in whose case the intimation email regarding the AGM has bounced back and the Notice could therefore not be delivered; and iv. Shareholders holding equity shares of the Company in physical form. We request you to take the above information on record. Thanking you, For Eiko Lifesciences Limited Chintan Doshi Company Secretary and Compliance Officer Membership No: A36190 Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com Sub.: Notice of 49thAnnual General Meeting (AGM) of Eiko LifeSciences Ltd and Annual Report for the Financial Year 2025-26. We are pleased to inform you that the 49th Annual General Meeting ('AGM') of the Members of Eiko LifeSciences Limited ('the Company') is scheduled to be held on Tuesday, 22nd day of September, 2026 at 04:00 P.M (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('SEBI Listing Regulations, 2015'), as amended, the web-link, including the exact path, where complete details of the Annual Report are available is required to be sent to those member(s) who have not registered their email address(es) either with the Company or with Depositories, or Bigshare Services Pvt Ltd, Registrar & Share Transfer Agent (RTA) of the Company. Accordingly, the web-link, including the path and the QR code, where complete details of the Annual Report for the Financial Year 2025-26 are available is: Weblink of Exact Path of https://www.eikolifesciences.com/pdf/annualreports/49TH_ANNUAL_REPO Annual Report 2025-26 RT_FY_25-26.pdf QR Code The Annual Report of the Company is also available on the websites of Stock Exchange i.e. BSE Limited ('BSE'), at www.bseindia.com Key details of the AGM are as under: Particulars Details Cut-off date of E-voting Wednesday, 16th September, 2026 E- Voting Start Date with Time Saturday, 19th September, 2026 at 9.00 A.M. (IST) E- Voting End Date with Time Monday, 21st September 2026 till 5.00 P.M. (IST) This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date i.e. 21st August, 2026. Should you have any queries, please feel free to contact the company on investor.relations@eikolifesciences.com You are also requested to update your e-mail address at the earliest with DP/RTA. Thanking you, Yours faithfully For, Eiko Lifesciences Ltd Sd/- Chintan Doshi Company Secretary & Compliance Officer ACS: 36190 Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com